home / stock / siox / siox news


SIOX News and Press, Sio Gene Therapies Inc. From 09/07/23

Stock Information

Company Name: Sio Gene Therapies Inc.
Stock Symbol: SIOX
Market: NASDAQ
Website: siogtx.com

Menu

SIOX SIOX Quote SIOX Short SIOX News SIOX Articles SIOX Message Board
Get SIOX Alerts

News, Short Squeeze, Breakout and More Instantly...

SIOX - Expected US Company Earnings on Thursday, September 7th, 2023

DocuSign Inc. (DOCU) is expected to report $0.11 for Q2 2024 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Concrete Pumping Holdings Inc. (BBCP) is expected to report $0.16 for Q3 2023 ...

SIOX - Expected earnings - Sio Gene Therapies Inc.

Sio Gene Therapies Inc. (SIOX) is expected to report for quarter end 2023-06-30

SIOX - Alluvial Capital Management Q1 2023 Letter To Partners

2023-04-28 03:30:00 ET Summary Alluvial Fund follows the same successful investment strategies used by Alluvial in managing separate accounts, focusing on value opportunities in small companies and thinly-traded issues, both domestically and internationally. Alluvial Fund began th...

SIOX - Sio Gene Therapies: Biopharma Liquidation With A Favorable Risk-Reward

2023-04-20 08:17:26 ET Summary This is a failed biopharma liquidation play with a favorable risk-reward. Sio Gene Therapies is undergoing liquidation, with its shareholders likely to receive $0.38-$0.42/share vs. the current price of $0.40/share. An additional upside of up to ...

SIOX - Sio Gene Therapies GAAP EPS of -$0.05

Sio Gene Therapies press release ( NASDAQ: SIOX ): Q3 GAAP EPS of -$0.05. As of December 31, 2022, we had $46.13 million of cash and cash equivalents. For further details see: Sio Gene Therapies GAAP EPS of -$0.05

SIOX - Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results

–  Three-Month and Nine-Month Losses decline by 84.2% and 73.5%, respectively –  Operating Cash Outflows for the Nine Months Ended December 31, 2022 decreased by $23.8 million or 56% versus the prior year period –  $46.1 million of c...

SIOX - Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution

NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (Nasdaq:SIOX) today announced that its Board of Directors has determined, after extensive and careful consideration of potential strategic alternatives, that it is in the best interests of the Company and its shareholders to diss...

SIOX - Sio Gene Therapies GAAP EPS of -$0.04 beats by $0.15

Sio Gene Therapies press release ( NASDAQ: SIOX ): Q2 GAAP EPS of -$0.04 beats by $0.15 . As of September 30, 2022, Company had $49.86 million of cash and cash equivalents. For further details see: Sio Gene Therapies GAAP EPS of -$0.04 beats by $0.15

SIOX - Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results

- Three-Month and Six-Month Losses decline by 85.5% and 65.3%, respectively - Operating Cash Outflows for the Six Months Ended September 30, 2022 decreased by $8.1 million or 37% versus the prior year period - Strong cash position with $49.86 million of cash and cash equiv...

SIOX - 3 Hot Penny Stocks To Buy For Under $1 Right Now

Cheap Penny Stocks to Buy For Under $1 If you’re watching the action in the stock market today, you’re seeing plenty of chop. The U.S. dollar’s strength has pushed broader markets lower, but a mix of positive and negative economic against this week’s PPI data...

Previous 10 Next 10